Correlation Between Apple and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apple and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apple and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apple Inc and Astellas Pharma, you can compare the effects of market volatilities on Apple and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and Astellas Pharma.

Diversification Opportunities for Apple and Astellas Pharma

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Apple and Astellas is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Apple i.e., Apple and Astellas Pharma go up and down completely randomly.

Pair Corralation between Apple and Astellas Pharma

Assuming the 90 days trading horizon Apple Inc is expected to generate 0.63 times more return on investment than Astellas Pharma. However, Apple Inc is 1.58 times less risky than Astellas Pharma. It trades about 0.11 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.09 per unit of risk. If you would invest  21,609  in Apple Inc on August 30, 2024 and sell it today you would earn a total of  701.00  from holding Apple Inc or generate 3.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Apple Inc  vs.  Astellas Pharma

 Performance 
       Timeline  
Apple Inc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Apple Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Apple may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Apple and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apple and Astellas Pharma

The main advantage of trading using opposite Apple and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind Apple Inc and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites